Open Data Revolution in Clinical Research: Opportunities and Challenges

Efforts for sharing individual clinical data are gaining momentum due to a heightened recognition that integrated data sets can catalyze biomedical discoveries and drug development. Among the benefits are the fact that data sharing can help generate and investigate new research hypothesis beyond tho...

Full description

Bibliographic Details
Main Authors: Mohamed H. Shahin, Sanchita Bhattacharya, Diego Silva, Sarah Kim, Jackson Burton, Jagdeep Podichetty, Klaus Romero, Daniela J. Conrado
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Clinical and Translational Science
Online Access:https://doi.org/10.1111/cts.12756
id doaj-7a8c30b9e10b483fbfa7e66b200ec0a3
record_format Article
spelling doaj-7a8c30b9e10b483fbfa7e66b200ec0a32020-11-25T03:01:43ZengWileyClinical and Translational Science1752-80541752-80622020-07-0113466567410.1111/cts.12756Open Data Revolution in Clinical Research: Opportunities and ChallengesMohamed H. Shahin0Sanchita Bhattacharya1Diego Silva2Sarah Kim3Jackson Burton4Jagdeep Podichetty5Klaus Romero6Daniela J. Conrado7Pfizer Global Research Groton Connecticut USABakar Computational Health Sciences Institute University of California, San Francisco San Francisco California USAFaculty of Health Sciences Simon Fraser University Vancouver British Columbia CanadaCenter for Pharmacometrics and Systems Pharmacology Department of Pharmaceutics College of Pharmacy University of Florida Orlando Florida USACritical Path Institute Tucson Arizona USACritical Path Institute Tucson Arizona USACritical Path Institute Tucson Arizona USAe‐Quantify La Jolla California USAEfforts for sharing individual clinical data are gaining momentum due to a heightened recognition that integrated data sets can catalyze biomedical discoveries and drug development. Among the benefits are the fact that data sharing can help generate and investigate new research hypothesis beyond those explored in the original study. Despite several accomplishments establishing public systems and guidance for data sharing in clinical trials, this practice is not the norm. Among the reasons are ethical challenges, such as privacy of individuals, data ownership, and control. This paper creates awareness of the potential benefits and challenges of sharing individual clinical data, how to overcome these challenges, and how as a clinical pharmacology community we can shape future directions in this field.https://doi.org/10.1111/cts.12756
collection DOAJ
language English
format Article
sources DOAJ
author Mohamed H. Shahin
Sanchita Bhattacharya
Diego Silva
Sarah Kim
Jackson Burton
Jagdeep Podichetty
Klaus Romero
Daniela J. Conrado
spellingShingle Mohamed H. Shahin
Sanchita Bhattacharya
Diego Silva
Sarah Kim
Jackson Burton
Jagdeep Podichetty
Klaus Romero
Daniela J. Conrado
Open Data Revolution in Clinical Research: Opportunities and Challenges
Clinical and Translational Science
author_facet Mohamed H. Shahin
Sanchita Bhattacharya
Diego Silva
Sarah Kim
Jackson Burton
Jagdeep Podichetty
Klaus Romero
Daniela J. Conrado
author_sort Mohamed H. Shahin
title Open Data Revolution in Clinical Research: Opportunities and Challenges
title_short Open Data Revolution in Clinical Research: Opportunities and Challenges
title_full Open Data Revolution in Clinical Research: Opportunities and Challenges
title_fullStr Open Data Revolution in Clinical Research: Opportunities and Challenges
title_full_unstemmed Open Data Revolution in Clinical Research: Opportunities and Challenges
title_sort open data revolution in clinical research: opportunities and challenges
publisher Wiley
series Clinical and Translational Science
issn 1752-8054
1752-8062
publishDate 2020-07-01
description Efforts for sharing individual clinical data are gaining momentum due to a heightened recognition that integrated data sets can catalyze biomedical discoveries and drug development. Among the benefits are the fact that data sharing can help generate and investigate new research hypothesis beyond those explored in the original study. Despite several accomplishments establishing public systems and guidance for data sharing in clinical trials, this practice is not the norm. Among the reasons are ethical challenges, such as privacy of individuals, data ownership, and control. This paper creates awareness of the potential benefits and challenges of sharing individual clinical data, how to overcome these challenges, and how as a clinical pharmacology community we can shape future directions in this field.
url https://doi.org/10.1111/cts.12756
work_keys_str_mv AT mohamedhshahin opendatarevolutioninclinicalresearchopportunitiesandchallenges
AT sanchitabhattacharya opendatarevolutioninclinicalresearchopportunitiesandchallenges
AT diegosilva opendatarevolutioninclinicalresearchopportunitiesandchallenges
AT sarahkim opendatarevolutioninclinicalresearchopportunitiesandchallenges
AT jacksonburton opendatarevolutioninclinicalresearchopportunitiesandchallenges
AT jagdeeppodichetty opendatarevolutioninclinicalresearchopportunitiesandchallenges
AT klausromero opendatarevolutioninclinicalresearchopportunitiesandchallenges
AT danielajconrado opendatarevolutioninclinicalresearchopportunitiesandchallenges
_version_ 1724692470878437376